Trifluoroacetic Acid

Trifluoroacetic Acid

SCHEMBL23149351

Fc1cc(C(F)(F)F)ccc1COC1CC2CNC1C2.O=C(O)C(F)(F)F

nearest known ligand 0.41

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ IDO1 P14902 1/20 0.41
▸ SLC6A4 P31645 2/20 0.39
▸ FFAR1 O14842 1/20 0.38
▸ P2RY14 Q15391 2/20 0.36
▸ TMEM97 Q5BJF2 1/20 0.36
▸ SLC6A2 P23975 1/20 0.36
▸ SLC6A3 Q01959 1/20 0.36
▸ DAO P14920 1/20 0.36
▸ NAAA Q02083 1/20 0.36
▸ ENPP2 Q13822 3/20 0.35
▸ ATXN2 Q99700 3/20 0.35
▸ TACR1 P25103 2/20 0.34
▸ S1PR1 P21453 1/20 0.34
▸ PRKX P51817 1/20 0.34
▸ IKBKE Q14164 1/20 0.34
▸ S1PR5 Q9H228 1/20 0.34
▸ MGLL Q99685 1/20 0.34
▸ LTC4S Q16873 1/20 0.34
▸ FFAR4 Q5NUL3 1/20 0.33
▸ KDM1A O60341 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Trifluoroacetic Acid SCHEMBL23149354 1.00 IDO1 (0.41) IDO1SLC6A4FFAR1P2RY14TMEM97
Trifluoroacetic Acid SCHEMBL23149348 1.00 IDO1 (0.41) IDO1SLC6A4FFAR1P2RY14TMEM97
SCHEMBL23105381 0.92 IDO1 (0.48) IDO1SLC6A4FFAR1P2RY14TMEM97
SCHEMBL23171801 0.92 IDO1 (0.48) IDO1SLC6A4FFAR1P2RY14TMEM97
SCHEMBL23171806 0.92 IDO1 (0.48) IDO1SLC6A4FFAR1P2RY14TMEM97
Trifluoroacetic Acid SCHEMBL21723023 0.83 SLC6A4 (0.44) IDO1SLC6A4FFAR1SLC6A2SLC6A3
Trifluoroacetic Acid SCHEMBL23149404 0.82 IDO1 (0.41) IDO1SLC6A4FFAR1P2RY14TMEM97
Trifluoroacetic Acid SCHEMBL23149406 0.82 IDO1 (0.41) IDO1SLC6A4FFAR1P2RY14TMEM97
Trifluoroacetic Acid SCHEMBL23152297 0.80 IDO1 (0.47) IDO1SLC6A4FFAR1SLC6A2SLC6A3
Trifluoroacetic Acid SCHEMBL23091803 0.78 NAAA (0.43) IDO1SLC6A4FFAR1SLC6A2SLC6A3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4028401-B1 4,4A,5,7,8,8A-HEXAPYRIDO[4,3-B][1,4]OXAZIN-3-ONE COMPOUNDS AS MAGL INHIBITORS HOFFMANN LA ROCHE (CH) 2023-11-22 — — EP disclosed
US-20220275005-A1 HETEROCYCLIC COMPOUNDS HOFFMANN-LA ROCHE INC. (US) 2022-09-01 — — US disclosed
US-20210094971-A1 HETEROCYCLIC COMPOUNDS HOFFMANN-LA ROCHE INC. (US) 2021-04-01 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210094971-A1 HETEROCYCLIC COMPOUNDS CYP1B1, CYP4B1, CYP4X1 IDO1 1248/4885SLC6A4 4287/4885FFAR1 4200/4885
US-20220275005-A1 HETEROCYCLIC COMPOUNDS CYP1B1, CYP4B1, CYP4X1 IDO1 1248/4885SLC6A4 4287/4885FFAR1 4200/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback